BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 3162824)

  • 21. Cell surface antigens expressed by subsets of pre-B cells and B cells.
    McKearn JP; Baum C; Davie JM
    J Immunol; 1984 Jan; 132(1):332-9. PubMed ID: 6606670
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Suppression of MHC class I antigens in oncogenic transformants: association with decreased recognition by cytotoxic T lymphocytes.
    Seliger B; Harders C; Wollscheid U; Staege MS; Reske-Kunz AB; Huber C
    Exp Hematol; 1996 Sep; 24(11):1275-9. PubMed ID: 8862437
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of a malignant phenotype-associated cell surface glycoprotein common to various human tumor cells and preferentially expressed on adenocarcinoma of the lung.
    Motté P; Takahashi H; Ozturk M; Wilson BE; Wands JR
    Cancer Res; 1989 Mar; 49(6):1349-56. PubMed ID: 2924292
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human oncogene-transfected tumor cells display differential susceptibility to lysis by lymphokine-activated killer cells (LAK) and natural killer cells.
    Lanza LA; Wilson DJ; Ikejiri B; Roth JA; Grimm EA
    J Immunol; 1986 Oct; 137(8):2716-20. PubMed ID: 3489774
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High levels of Met-72 antigen expression: correlation with metastatic activity of B16 melanoma tumor cell variants.
    Kimura AK; Xiang JH
    J Natl Cancer Inst; 1986 Jun; 76(6):1247-54. PubMed ID: 3486997
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Two surface antigens expressed on proliferating mouse T lymphocytes defined by rat monoclonal antibodies.
    Takei F
    J Immunol; 1983 Jun; 130(6):2794-7. PubMed ID: 6304191
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anti-Thy-1 antibody responses evoked by Thy-1 antigen expressed in transfected mouse mastocytoma cells and rat fibroblast.
    Isobe K; Fortunato A; Giguere V; Grosveld F; Mitchison NA
    Immunology; 1985 Nov; 56(3):505-12. PubMed ID: 2867029
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular cloning of rat NK target structure--the possibility of CD44 involvement in NK cell-mediated lysis.
    Kanki K; Torigoe T; Hirai I; Sahara H; Kamiguchi K; Tamura Y; Yagihashi A; Sato N
    Microbiol Immunol; 2000; 44(12):1051-61. PubMed ID: 11220679
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of a tumor-associated target antigen, ATM-1, for a human T-cell clone with activated killer activity and its existence in sera of cancer patients.
    Kaieda T; Imawari M; Yamasaki Z; Ohnishi S; Koike M; Idezuki Y; Takaku F
    Cancer Res; 1988 Sep; 48(17):4848-54. PubMed ID: 3044579
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transformation-associated 86 kDa natural killer target molecule expressed on the mouse, rat and human cell surface.
    Qi W; Tamura Y; Takashima S; Sato N; Kikuchi K
    Jpn J Cancer Res; 1994 Aug; 85(8):862-8. PubMed ID: 7928633
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Malignant human B cells express two populations of p24 surface antigens.
    Pesando JM; Hoffman P; Conrad T
    J Immunol; 1986 Apr; 136(7):2709-14. PubMed ID: 3485154
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lymphokine-activated killer cells in rats: analysis of progenitor and effector cell phenotype and relationship to natural killer cells.
    Vujanovic NL; Herberman RB; Olszowy MW; Cramer DV; Salup RR; Reynolds CW; Hiserodt JC
    Cancer Res; 1988 Feb; 48(4):884-90. PubMed ID: 3257412
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Malignant transformation of human fibroblasts by a transfected N-ras oncogene.
    Wilson DM; Yang DJ; Dillberger JE; Dietrich SE; Maher VM; McCormick JJ
    Cancer Res; 1990 Sep; 50(17):5587-93. PubMed ID: 2201439
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cell surface antigens of chemically induced fibrosarcomas: detection by a monoclonal antibody of a tumor-restricted Mr 12,000 protein gag antigen encoded by a dual-tropic murine leukemia virus.
    Carbone G; Pierotti MA; Boiocchi M; De Leo AB; Ballinari D; Radice P; Borrello MG; Meseguer A; Cernuschi A; Parmiani G
    Cancer Res; 1985 Oct; 45(10):4980-5. PubMed ID: 2992769
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Murine T lymphoma cells express a novel membrane-associated antigen with unique features.
    Takei F
    J Immunol; 1987 Jul; 139(2):649-54. PubMed ID: 3496386
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MALA-1: a surface antigen expressed on activated murine T and B lymphocytes.
    Takei F
    J Immunol; 1984 Jul; 133(1):345-50. PubMed ID: 6609986
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tissue distribution, immunochemical characterization, and biosynthesis of 47D10, a tumor-associated surface glycoprotein.
    Ho MK; Kato KP; Durda PJ; Murray JH; Wolfe H; Rabin H; Carney WP
    Cancer Res; 1987 Jan; 47(1):241-50. PubMed ID: 3539319
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Natural killer activity in the rat. III. Characterization of transplantable large granular lymphocyte (LGL) leukemias in the F344 rat.
    Reynolds CW; Bere EW; Ward JM
    J Immunol; 1984 Jan; 132(1):534-40. PubMed ID: 6197459
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of tumor cell growth in vitro by murine monoclonal antibodies that recognize a proliferation-associated cell surface antigen system in rats and humans.
    Yagita H; Masuko T; Hashimoto Y
    Cancer Res; 1986 Mar; 46(3):1478-84. PubMed ID: 2417704
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A novel differentiation antigen on proliferating murine thymocytes identified by a rat monoclonal antibody.
    Takei F
    J Immunol; 1984 Feb; 132(2):766-71. PubMed ID: 6418809
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.